Overview In this role you will lead scientific engagement with KOLs, HCPs, researchers, and decision-makers to advance Regeneron's oncology programs. You'll act as the primary clinical resource on disease state and product information, shaping medical strategy and evidence generation. You will build and sustain KOL networks, support company-sponsored trials and IIS, and report medical insights to inform cross-functional partners. This role places you at the intersection of science, medicine, and strategic execution to drive meaningful patient impact. Compensation / Benefitsannual bonuses or incentive plansequity awards401(k) company matchhealth and wellness programspaid time offfamily support benefits ResponsibilitiesEstablish and maintain relationships with KOLs and experts in thoracic malignancies and solid tumorsServe as the primary clinical/scientific resource for HCPs on disease state and productsIdentify relevant medical/therapeutic area experts and develop engagement plansSupport evidence generation through company-sponsored trials and IISIdentify gaps in research and educational needs to inform medical strategyRespond to information requests and present scientific/clinical data in a compliant mannerConduct disease management and therapeutic education with practitioners, payers, and researchersAttend medical conferences to collect and report scientific, clinical, and competitive intelligenceEnsure adherence to company policies, procedures, and financial controls Key requirements8+ years of experience in a Medical Science Liaison role with oncology focus (minimum 4 years in Oncology MSL)Terminal scientific degree (MD, PharmD, PhD, DNP or DVM)Knowledge of Oncology therapeutic area; thoracic malignancies preferredEstablished KOL relationships in thoracic malignancies; connections with institutions focused on Solid Tumor Malignancies preferredDrug launch experience strongly preferredKnowledge of treatment guidelines, clinical research processes, FDA/pharma regulations, and OIG guidelinesResidency in the assigned territory and valid driver's license with clean driving recordEffective written and verbal communicationStakeholder engagement and relationship buildingCross-functional collaborationOncology therapeutic area expertiseMedical information exchange and compliant data discussionClinical trial understanding (phases, IIS)
Not specified in the original listing.
Not specified in the original listing.
